Mersana Therapeutics logo
Mersana Therapeutics
MRSN | NASDAQ
Chart Builder DCF Calculator
$29.08
$0.00 (0.00%)
At close: Jan 5, 2026, 3:55 PM ET

Mersana Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
-69.19M -171.67M -204.21M -170.06M -88.05M -28.21M
1.63M 1.52M 927K 855K 1.01M 1.25M
16.46M 21.14M 21.52M 18.41M 7.17M 4.87M
-27.88M -42.68M 162.15M 9.6M 4.16M -41.38M
-496K -1.1M -699K 723K 62K 103K
– – – – – -222K
-30.74M -18.76M 133.1M 10.09M 5.11M -45.53M
-82.34M -168.88M -49.36M -139.99M -74.7M -67.74M
-132K -2.17M -2.2M -648K -473K -605K
– – 150.52M – – 26.69M
-133.43M -155.92M -247.52M – – -53.69M
145M 277.97M 97M – 37.5M 27M
– – -150.52M – – -26.69M
11.44M 119.88M -152.72M -648K 37.03M -27.29M
-2.23M -262K -272K 18.34M -313K 4.88M
– – – – – –
– – – – – –
542K 1.4M 2.4M 2.22M 3.7M 664K
4.09M 94.68M 153.02M 63.65M 230.41M 97.7M
-66.81M 45.68M -49.06M -76.99M 192.74M 2.67M
-82.47M -171.05M -51.56M -140.64M -75.17M -68.35M
-98.93M -192.19M -73.08M -159.05M -82.34M -73.22M
– – – -648K -473K –
-132K -2.17M -2.2M – – -605K
-82.34M -168.88M -49.36M -140.64M -75.17M -67.74M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.